Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliate, Fortune China Ltd. in a USD 5 million investment in Vascular Graft Solutions Ltd.
Vascular Graft Solutions Ltd. is a developer of innovative solutions to improve the outcome of bypass surgery and patients’ quality of life.
Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Ltd. were represented by Timor Belan (Partner) and Assaf Harel.
